Related Experiment Video
Updated: Jul 8, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Heart failure and sudden death in dilated cardiomyopathy: a hidden competition we should not forget about when
Dario Gregori1, Rosalba Rosato, Massimo Zecchin
1Department of Public Health and Microbiology, University of Torino, Torino, Italy. dario.gregori@unito.it
Insights
This study analyzes mortality in dilated cardiomyopathy using bivariate survival curves and a competing risk Cox model. Ignoring competing risks can mislead results, highlighting the importance of this analytical approach for heart failure and sudden death.
Area of Science:
- Cardiology
- Biostatistics
- Survival Analysis
Background:
- Dilated cardiomyopathy presents significant mortality risks from heart failure (HF) and sudden death (SD).
- Traditional survival analysis often assumes independence between competing events, which may not hold true in clinical settings.
- Accurate analysis of mortality in dilated cardiomyopathy requires methods that account for competing risks.
Purpose of the Study:
- To propose a protocol for analyzing competing risk events in dilated cardiomyopathy, mirroring univariate analysis approaches.
- To apply non-parametric bivariate survival estimators and a competing risk Cox model to mortality data.
- To investigate mortality patterns for heart failure and sudden death without assuming independence.
Main Methods:
- Utilized non-parametric bivariate survival estimators to model competing risks of HF and SD.
- Applied a multivariate proportional hazard model to a prospective cohort of 235 dilated cardiomyopathy patients (1978-1992).
- Stratified analysis by age, severity, and treatment, considering both intention-to-treat and actual treatment protocols.
Main Results:
- Bivariate survival curves revealed distinct mortality patterns for HF (early, then slowing) and SD (late increase).
- Competing risk analysis identified a treatment effect only under the actual treatment protocol.
- Standard Cox regression analysis did not reveal the same treatment effect, indicating potential misinterpretation.
Conclusions:
- Non-parametric bivariate survival estimation offers interpretable parameters similar to standard Cox regression.
- Accounting for competing risks is crucial to avoid misleading interpretations in dilated cardiomyopathy mortality studies.
- The proposed protocol provides a robust framework for analyzing competing risks in clinical research.
Rationale, Aims And Objectives:
This paper discusses the use of bivariate survival curve estimators jointly with a competing risk Cox model to analyse mortality in dilated cardiomyopathy due to heart failure (HF) or sudden death (SD), without assuming independence between outcomes. The goal of the manuscript is to suggest a possible protocol for the analysis of competing risk events, mimicking the common approaches used in the univariate case.
Methods:
The non-parametric bivariate survival estimators are used to estimate a multivariate proportional hazard model for dealing with SD or HF in a long-term prospective cohort of 235 patients, recruited from 1978 to 1992. Patients have been stratified, among others, by age, severity and treatment. The latter has been considered under two specific protocols of analysis: intention to treat and actual treatment.
Results:
The bivariate survival curves show different survival probabilities for HF and SD. For HF the force of mortality acts early and then slows down as follow-up increases, while for SD the mortality is lower initially and increases later in time. Under competing risk analysis, evidence of treatment effect is shown only in the actual treatment protocol, in contrast with the results provided by standard Cox regression.
Conclusions:
One of the advantages of non-parametric bivariate survival estimation in the presence of competing risks is that parameters may be interpreted in much the same way as those estimated by the standard Cox regression. Moreover, ignoring the competing risk structure may provide a misleading interpretation of the results.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy II: Dilated Cardiomyopathy
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Heart Failure I: Introduction

